Studies of sphingomyelin and sphingomyelinases

Chemistry and Physics of Lipids

Volumn 102, Issue 1-2, 1999, Pages 45-53

  Gatt, Shimon ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Phospholipase C; Sphingomyelinases; Sphinogmyelin

Indexed keywords

SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

CYTOLOGY; ENZYME ACTIVITY; ENZYME PURIFICATION; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032870264     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(99)00074-2     Document Type: Article

References (81)

1. Agmon V., Dinur T., Cherbu S., Dagan A., Gatt S. Administration of pyrene lipids by receptor-mediated endocytosis and their degradation in skin fibroblasts. Exp. Cell Res. 196:1991;151-157.
2. Agmon V., Monti E., Dagan A., Preti A., Marchesini S., Gatt S. Diagnosis of lipid storage diseases using the culture medium of skin fibroblasts. Clin. Chim. Acta. 218:1993;139-147.
3. Barenholz, Y., Gatt, S., 1982. Sphingomyelin: metabolism, chemical synthesis, chemical and physical properties. In: Hawthorne, J.N., Ansell, G.B. (Eds.), Comprehensive Biochemistry. Elsevier, Amsterdam, pp. 129-177.
4. Barenholz Y., Roitman A., Gatt S. Enzymatic hydrolysis of sphingolipids. II. Hydrolysis of sphingomyelin by an enzyme from rat brain. J. Biol. Chem. 241:1966;3731-3737.
5. Ben-Haim R., Yedgar S., Barenholz Y., Gatt S. Hydrolysis of sphingomyelin at an air-water interface by sphingomyelinase of Bacillus cereus. Isr. J. Med. Sci. 13:1977;132.
6. Cohen R., Barenholz Y., Gatt S., Dagan A. Synthesis and characterization of well-defined D-erythro sphingomyelins. Chem. Phys. Lipids. 35:1984;371-384.
7. Dinur T., Schuchman E.H., Fibach E., Dagan A., Suchi M., Desnick R.J., Gatt S. Toward gene therapy for Niemann-Pick disease (NPD): separation of retroviral corrected and non-corrected NPD fibroblasts using a novel fluorescent sphingomyelin. Hum. Gene Ther. 3:1992;633-699.
8. Dole V.P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J. Clin. Invest. 35:1972;150-154.
9. Epstein M., Avital Y., Agmon V., Dinur T., Fibach E., Gatt S., Laufer N. Use of fluorescent lipids for diagnosing a murine embryo model of Gaucher disease. Hum. Reprod. 8(2):1993;302-309.
10. Erlich, S., Miranda, S.R.P., Visser, J.W.M., Dagan, A., Gatt, S., Schuchman, E.H., 1999. Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelianse deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures. Blood 93, 80-86.
11. Frohwein Y.Z., Gatt S. Separation of β-N-acetylglucosaminidase and β-N-acetylgalactosaminidase from calf brain cytoplasm. Biochim. Biophys. Acta. 128:1966;216-218.
12. Frohwein Y.Z., Gatt S. Isolation of β-N-acetylhexosaminidase, β-N-acetylglucosaminidase and β-N-acetylgalactosaminidase from calf brain. Biochemistry. 6:1967;2775-2782.
13. Frohwein Y.Z., Gatt S. Enzymatic hydrolysis of sphingolipids. Hydrolysis of ceramide glycosides by calf brain β-N-acetylhexosaminidase. Biochemistry. 6:1967;2783-2787.
14. Gatt S. Enzymatic hydrolysis of sphingolipids: hydrolysis and synthesis of ceramides by an enzyme from rat brain. J. Biol. Chem. 241:1963;3724-3730.
15. Gatt S. Comparison of four enzymes from brain which hydrolyze sphingolipids. Volk B., Aronson S.M. Inborn Disorders of Sphingomyelin Metabolism. 1966;261-266 Pergamon Press, Oxford.
16. Gatt S. Enzymic hydrolysis of sphingolipids. Hydrolysis of ceramide glucoside by an enzyme from ox brain. Biochem. J. 101:1966;687-691.
17. Gatt S. Purification and properties of phospholipase A1 from rat and calf brain. Biochim. Biophys. Acta. 159:1968;304-316.
18. Gatt S. Enzymatic hydrolysis of sphingolipids. Lowenstein J.M., Clayton R.B. Lipid Metabolism, Methods in Enzymology. 14:1969;134-139 Academic Press, New York.
19. Gatt S. Enzymatic aspects of sphingolipid degradation. Chem. Phys. Lipids. 5:1970;235-249.
20. Gatt S. Magnesium-dependent sphingomyelinase. Biochem. Biophys. Res. Commun. 68:1976;235-242.
21. Gatt S. Galli C., Galli G., Paoletti G. Brain Sphingomyelinases in Phospholipases and Prostaglandins. 1978;1-10 Raven Press, New York.
22. Gatt S. Ansell G.B., Horrocks L.A., Porcellati G. Studies of Sphingomyelinase in Phospholipid Metabolism of the Nervous System. 1982;181-197 Raven Press, New York.
23. Gatt S. Administration of fluorescence derivatives of lipids into cultured cells and its use for detecting disorders of lipid metabolism. Salvayre R., Douste-Blazy L., Gatt S. Lipid Storage Disorders. 1988;571-582 Plenum Press, New York.
24. Gatt, S., 1972. In: Zambotti, V., Tettamanti, G., Arrigoni, M. (Eds.), Enzymatic Aspects of Sphingolipid Metabolism in Glycolipids, Glucoproteins and Mucopolysaccharides in the Nervous System. Plenum Press, pp. 131-150.
25. Gatt, S., 1974. Interaction between lysosomal enzymes and their substrates in particular lipids. In: Tager, J.M., Hooghwinkel, G.J.M. and Daems, W.Th. (Eds.), Enzyme Therapy in Lysosomal Diseases. North Holland, Amsterdam, pp. 207-215.
26. Gatt S., Baker E.A. Purification and separation of α- and β-galactosidases from spinach leaves. Biochim. Biophys. Acta. 206:1970;125-135.
27. Gatt S., Bierman E.L. Sphingomyelin suppresses the binding and utilization of low density lipoproteins by skin fibroblasts. J. Biol. Chem. 255:1980;3371-3376.
28. Gatt S., Gottesdiner T. Solubilization of sphingomyelinase by isotonic extraction of rat brain lysosomes. J. Neurochem. 23:1975;421-422.
29. Gatt S., Rapport M.M. Hydrolysis of ceramide lactoside and ceramide glucoside by glycosidases from brain. Isr. J. Med. Sci. 1:1965;624-627.
30. Gatt S., Rapport M.M. Isolation of β-galactosidse and β-glucosidase from brain. Biochim. Biophys. Acta. 113:1966;567-576.
31. Gatt S., Rapport M.M. Enzymic hydrolysis of sphingolipids. Hydrolysis of ceramide lactoside by an enzyme from rat brain. Biochem. J. 101:1996;680-686.
32. Gatt S., Barenholz Y., Roitman A. Isolation of rat brain lecithinase-A1 specific for the α′-position of lecithin. Biochem. Biophys. Res. Commun. 24:1966;169-172.
33. Gatt S., Herzl A., Barenholz Y. Hydrolysis of sphingomyelin liposomes by sphingomyelinase. FEBS Lett. 30:1973;281-285.
34. Gatt S., Dinur T., Kopolovic J. Niemann-Pick disease: presence of the magnesium-dependent sphingomyelinase in brain of the infantile form of the disease. J. Neurochem. 31:1978;547-550.
35. Gatt S., Dinur T., Barenholz Y. A spectrophotometric method for determination of sphingomyelinase. Biochim. Biophys. Acta. 530:1978;503-507.
36. Gatt S., Dinur T., Yedgar S., Leibovitz Ben-Gershon Z. Effect of detergents on the utilization of sphingomyelin by brain sphingomyelinases. Gatt S., Freysz L., Mandel P. Enzymes of Lipid Metabolism. 1978;487-500 Plenum Press, New York.
37. Gatt S., Dinur T., Leibovitz-Ben Gershon Z. Magnesium dependent sphingomyelinase of infantile brain. Effect of detergents and a heat stable factor. Biochim. Biophys. Acta. 531:1978;206-214.
38. Gatt S., Dinur T., Barenholz Y. A fluorometric procedure for determination of sphingomyelinase using fluorescent derivatives of sphingomyelin and its applications to the diagnosis of Niemann-Pick disease. Clin. Chem. 26:1980;93-96.
39. Gatt, S., Barenholz, Y., Goldberg, R., Dinur, T., Besley, G., Leibovitz-Ben Gershon, Z., Rosenthal, J., Desnick, R.J., Devine, E.A., Shafit-Zagardo, B., Tsuruki, F., 1981. Assay of enzymes of lipid metabolism with colored and fluorescent derivatives of natural lipids. In: Lowenstein, J.M. (Ed.), Methods in Enzymology, vol. 72, pp. 351-375.
40. Gatt, S., Dinur, T., Barenholz, Y., 1981. Assay of sphingomyelinase using fluorescent derivatives of sphingomyelin. In: Lowenstein, J.M. (Ed.), Methods in Enzymology, vol. 72. Academic press, pp. 356-360.
41. Gatt S., Dinur T., Abou-Rabia S., Kotler M., Fibach E. Photosensitization of cultured cells and viruses by pyrene lipids. Ind. J. Biochem. 27:1990;359-362.
42. Gatt S., Dinur T., Karabat S., Dagan A., Agmon V. Use of liposomes for administering fluorescent lipids and studying their metabolism in normal and lipidotic cells of liposomes. Barenholz Y., Lasic D. Handbook of Non-Medical Applications. 2:1996;137-152 Plenum Press, New York.
43. Gatt S., Dinur T., Cerbu-Karabat S., Agmon V., Dagan A. Use of fluorescent derivatives for labelling cells; diagnosing, preventing and correcting genetic diseases; photosynthesizing and killing of tumors, parasites and viruses. Kohen E. Analytical Use of Fluorescent Probes in Oncology. 1996;299-308 Plenum Press, New York.
44. Gatt, S., Agmon, V., Dinur, T., Dagan, A., 1997. Application of fluroescence for studying normal and pathological metabolism in intact cells. In: Kohen, E. (Ed.). Research Signpost Publisher, pp. 152-172.
45. Gatt, S., Agmon, V., Dagan, A., Dinur, T., 1999. Synthesis of fluorescent substrates and their application to the study of sphingolipid metabolism, in vitro and intact cells. In: Merrill A.H., Hannum Y.A. (Eds.), Methods in Enzymology - Sphingolipid Metabolism and Cell Signalling, in press (Academic press).
46. Gottesdiner T., Gatt S. Solubilization of sphingomyelinase of rat brain lysosomes. Isr. J. Med. Sci. 11:1975;1195.
47. Gottesdiner T., Gatt S. Hydrolysis of sphingomyelin by the magnesium-dependent sphingomyelinase of human brain. Isr. J. Med. Sci. 13:1977;130.
48. He, X., Miranda, S.R.P., Dagan, A., Gatt, S., Schuchman, E.H., 1999. Overexpression of human acid sphingomyelinase in Chinese hamster ovary cells: purification and characterization of the recombinant enzyme (in press).
49. Heller M., Shapiro B. Enzymatic hydrolysis of sphingomyelin by rat liver. Biochem. J. 98:1966;763-869.
50. Kanfer J.N., Young D.N., Shapiro D., Brady R.O. The metabolism of spingomyelin. Purification and properties of a sphingomyelincleaving enzyme from rat liver tissue. J. Biol. Chem. 240:1966;1081-1084.
51. Klar R., Levade T., Gatt S. Synthesis of pyrene sulfonylamidosphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease. Clin. Chim. Acta. 176:1988;259-268.
52. Leibovitz Z., Gatt S. Enzymatic hydrolysis of sphingolipids. Hydrolysis of gangliosides by a neuraminidase from calf brain. Biochim. Biophys. Acta. 152:1968;136-143.
53. Levade T., Gatt S. Uptake and intracellular degradation of fluorescent sphingomyelin by fibroblasts from normal individuals and a patient with Niemann-Pick disease. Biochim. Biophys. Acta. 918:1987;250-259.
54. Levade, T., Klar, R., Dagan, A., Cherbu, S. and Gatt, S., 1986. Fluorescent derivatives of sphingomyelin: synthesis, use as substrates for sphingomyelinase and for diagnosis of Niemann-Pick disease in cultured cells. In: Freysz, L., Dreyfus, H., Massarelli, R., Gatt, S. (Eds.), Enzymes of Lipid Metabolism, vol. 2. Plenum Press, New York, pp. 803-808.
55. Levade T., Salvayre R., Gatt S. Enhancement of fluorescence of pyrene-containing lipids by polar media, detergents and phospholipids. Experienzia. 43:1987;1002-1005.
56. Levade T., Klar R., Kaufmann R., Desnick R.J., Grabowski G.A., Gatt S. Determination of sphingomyelinase activity in cells and body fluids using a new fluorescent derivative of sphingomyelin. Application to diagnosis of Niemann-Pick disease. Salvayre R., Douste-Blazy L., Gatt S. Lipid Storage Disorders. 1988;503-510 Plenum Press, New York.
57. Levade T., Gatt S., Salvayre R. Uptake and degradation of several pyrene-sphingomyelins by human skin fibroblasts from controls and Niemann-Pick disease: effect of the structure of the fluorescent fatty acyl residue. Biochem. J. 275:1991;211-218.
58. Levade T., Gatt S., Maret A., Salvayre R. Different pathways of uptake and degradation of sphingomyelin by lymphoblastoid cells and the potential participation of the neutral sphingomyelinase. J. Biol. Chem. 266:1991;13519-13529.
59. Levade Th., Vidal F., Gatt S., Vermeersch S., Andieu N., Salvayre R. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway. Biochim. Biophys. Acta. 1258:1995;277-287.
60. Lichtenberg D., Yedgar S., Gatt S. Proton resonance studies on mixed dispersions of Triton X-100 and sphingomyelin. Isr. J. Med. Sci. 13:1977;134.
61. Lichtenberg D., Yedgar S., Gatt S. Studies on the molecular packing of dispersions of sphingomyelin and Triton X-100 and its dependence on temperature and cloudpoint. Biochemistry. 18:1979;2574-2582.
62. Mader Sahpiro, L., Dinur, T., Dagan, A., Gatt, S., Horowitz, M., 1999. Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators. J. Inherited Metabolic Diseases 22, 623-637.
63. Marchesini S., Gatt S., Agmon V., Guidi M.L., Monti E. A novel fluorescent indicator for the acidic range. Biochem. Int. 27:1992;545-550.
64. Miranda S.R.P., Erlich S., Visser J.W.M., Gatt S., Dagan A., Friedrich V.L., Schuchman E.H. Bone marrow transplantation in acid sphingomyelinase deficient mice. Engraftment and cell migration into the brain as a function of radiation, age and phenotype. Blood. 90:1997;444-452.
65. Miranda S.R.P., Erlich S., Friedrich V.L. Jr, Haskins M.E., Gatt S., Schuchman E.H. Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase deficient mice. J. Transplant. 65:1998;884-892.
66. Rao B.G., Spence M.W. Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J. Lipid Res. 17:1976;506-515.
67. Record M., Loyter Y., Gatt S. Utilization of membranous lipid substrates by membranous enzymes. Hydrolysis of sphingomyelin in erythrocyte ghosts and liposomes by the membranous sphingomyelinase of chicken erythrocyte ghosts. Biochem. J. 187:1980;115-121.
68. Roitman A., Gatt S. Isolation of phospolipase C from rat brain. Isr. J. Chem. 1:1963;190.
69. Rousseau A., Livni N., Gatt S. Utilization of membranous lipid substrates by membranous enzymes. Activation of the latent sphingomyelinase of hen erythrocyte membrane. Arch. Biochem. Biophys. 244:1986;838-845.
70. Schneider P.B., Kennedy E.P. Sphingomyelinase in normal human spleens and in spleens of patients with Niemann-Pick disease. J. Lipid Res. 8:1967;202-209.
71. Suchi M., Dinur T., Desnick R.J., Gatt S., Pereira L., Gilboa E., Schuchman H. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells. Proc. Natl. Acad. Sci. 89:1992;3227-3231.
72. Wolman M., Sterk U.V., Gatt S., Frenkel M. Primary familial xanthomatosis with involvement and calcification of the adrenals. Pediatrics. 28:1961;742-759.
73. Yavin Y., Gatt S. Further purification and properties of rat brain ceramidase. Biochemistry. 8:1969;1692-1698.
74. Yedgar S., Gatt S. Kinetic aspects of the stimulation of enzymatic hydrolysis of sphingomyelin by Triton-X100. Isr. J. Med. Sci. 11:1975;1172.
75. Yedgar S., Gatt S. Effect of Triton X-100 on the hydrolysis of sphingomyelin by sphingomyelinase of rat brain. Biochemistry. 15:1976;2570-2579.
76. Yedgar S., Gatt S. Enzymatic hydrolysis of sphingomyelin in the presence of bile salts. Biochem. J. 185:1980;749-754.
77. Yedgar S., Barenholz Y., Copper G.U., Gatt S. Correlation of physical properties and enzymatic hydrolysis of sphingomyelin in mixed detergent-substrate micelles. Isr. J. Med. Sci. 9:1973;240.
78. Yedgar S., Hertz R., Gatt S. Solubilization of sphingomyelin by Triton X-100. Effect of the method of mixing and the concentration of detergent and lipid. Chem. Phys. Lipids. 13:1974;404-414.
79. Yedgar S., Morag R., Gatt S. Hydrolysis of rat brain sphingomyelinase in the presence of bile salts. Isr. J. Med. Sci. 13:1977;131.
80. Yedgar S., Cohen R., Gatt S., Barenholz Y. Hydrolysis of monomolecular layers of synthetic sphingomyelins by sphingomyelinase of Staphylococcus aureus. Biochem. J. 201:1982;597-603.
81. Yeyati P.L., Agmon V., Dinur T., Fillat C., Dagan A., Desnick R.J., Gatt S., Schuchman E.H. Preparative isolation of metabolically-corrected Niemann-Pick disease cells for gene therapy: evidence for bystander correction of transduced cells. Hum. Gene Ther. 6:1995;975-983.